Anthony Fauci, NIAID director (AP Images)

NIH spot­lights trio of aca­d­e­m­ic teams chas­ing af­ter 'pan-coro­n­avirus' vac­cines

Hav­ing made loud and clear its call for new re­search on vac­cines that can tack­le fu­ture pan­demics, the NIH is shed­ding light on some of the projects it’s fund­ing.

The Na­tion­al In­sti­tute of Al­ler­gy and In­fec­tious Dis­eases (NI­AID) has award­ed around $36.3 mil­lion to three aca­d­e­m­ic groups that are work­ing on de­vel­op­ing “pan-coro­n­avirus vac­cines” — in­oc­u­la­tions that can pro­tect against a di­verse fam­i­ly of coro­n­avirus­es, es­pe­cial­ly the vo­ra­cious ones like SARS-CoV-2.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.